Skip to main content

Aptevo Therapeutics Inc.

APVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001671584

No open-market purchases or sales by Aptevo Therapeutics Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $224.3K in total; no superinvestor holds it.

Holders of 5% or more of APVO

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aptevo Therapeutics Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of APVO
HolderLatest formStakeChangeFirst filedLatest filingFiling
Ayrton Capital LLC13G10.00%358.1K sharesNewAug 13, 20251 filingAug 13, 2025SEC
YA II PN, Ltd.13G9.99%357.8K sharesNewJul 8, 20251 filingJul 8, 2025SEC
Bigger Capital Fund L P13G9.95%285.0K shares+3.75 ppfrom 6.20%Apr 8, 20252 filingsJun 25, 2025SEC
Point72 Asset Management, L.P.13G9.10%299.9K sharesNewSep 17, 20251 filingSep 17, 2025SEC
CVI Investments, Inc.13G/A8.20%83.9K shares−1.70 ppfrom 9.90%Apr 10, 20253 filingsFeb 17, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

21 Schedule 13D and 13G filings on Aptevo Therapeutics Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on APVO
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 17, 20262:46 PM ETCVI Investments, Inc.and 1 other13G/A8.20%83.9K shares−1.70 ppfrom 9.90%Dec 31, 2025SEC
Nov 7, 20251:39 PM ETBank of America Corp13G/A0.00%86 shares−15.00 ppfrom 15.00%Below 5%Oct 31, 2025SEC
Oct 6, 20254:26 PM ETBank of America Corp13G15.00%494.3K sharesNewSep 30, 2025SEC
Sep 17, 20255:26 PM ETPoint72 Asset Management, L.P.and 2 others13G9.10%299.9K sharesNewSep 16, 2025SEC
Aug 14, 20256:59 PM ETL1 Capital Global Opportunities Master Fund, Ltd.13G/A4.99%164.3K shares−4.96 ppfrom 9.95%Below 5%Aug 14, 2025SEC
Aug 14, 20252:00 PM ETCVI Investments, Inc.and 1 other13G/A9.90%357.8K shares+3.70 ppfrom 6.20%Jun 30, 2025SEC
Aug 13, 20256:28 AM ETAyrton Capital LLCand 2 others13G10.00%358.1K sharesNewJun 30, 2025SEC
Jul 8, 20252:11 PM ETYA II PN, Ltd.and 7 others13G9.99%357.8K sharesNewJun 16, 2025SEC
Jun 25, 20254:38 PM ETIntracoastal Capital, LLCand 2 others13G0.00%0 shares0.00 ppfrom 0.00%Below 5%Jun 18, 2025SEC
Jun 25, 20254:30 PM ETBigger Capital Fund L Pand 2 others13G9.95%285.0K shares+3.75 ppfrom 6.20%Jun 18, 2025SEC
Jun 23, 20254:08 PM ETL1 Capital Global Opportunities Master Fund, Ltd.13G9.95%285.0K shares+9.25 ppfrom 0.70%Jun 18, 2025SEC
Jun 23, 20254:07 PM ETL1 Capital Global Opportunities Master Fund, Ltd.13G/A0.70%20.0K shares−6.89 ppfrom 7.59%Below 5%Apr 26, 2025SEC
Apr 25, 20254:07 PM ETIntracoastal Capital, LLCand 2 others13G0.00%0 shares0.00 ppfrom 0.00%Below 5%Apr 21, 2025SEC
Apr 25, 20254:05 PM ETL1 Capital Global Opportunities Master Fund, Ltd.13G7.59%421.0K shares+2.60 ppfrom 4.99%Apr 21, 2025SEC
Apr 25, 20254:01 PM ETL1 Capital Global Opportunities Master Fund, Ltd.13G/A4.99%277.0K shares−1.22 ppfrom 6.21%Below 5%Apr 21, 2025SEC
Apr 10, 202510:14 AM ETCVI Investments, Inc.and 1 other13G6.20%200.0K sharesNewApr 3, 2025SEC
Apr 9, 20255:31 PM ETIntracoastal Capital, LLCand 2 others13G0.00%0 sharesNewBelow 5%Apr 3, 2025SEC
Apr 8, 20258:00 PM ETBigger Capital Fund L Pand 2 others13G6.20%200.0K sharesNewApr 3, 2025SEC
Apr 7, 20254:51 PM ETL1 Capital Global Opportunities Master Fund, Ltd.13G6.21%200.0K sharesNewApr 2, 2025SEC
Feb 10, 20256:58 PM ETHudson Bay Capital Management LPand 1 other13G/A4.99%76.6K shares0.00 ppfrom 4.99%Below 5%Dec 31, 2024SEC
Feb 10, 20254:24 PM ETHudson Bay Capital Management LP13G/A4.99%76.6K shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Aptevo Therapeutics Inc. shares.

No Form 144 notices for Aptevo Therapeutics Inc. are on file.